Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 6 (KRT18P6) is a human pseudogene within the type I keratin gene family, officially recognized and catalogued by the HGNC[4][5]. Unlike protein-coding keratin genes such as KRT18 (Keratin 18), KRT18P6 does not encode a functional protein and is classified as a pseudogene. Pseudogenes arise from gene duplication or retrotransposition events and generally lack protein-coding capacity, regulatory function, or clinical relevance. There is no evidence supporting a role for KRT18P6 as a receptor, enzyme, transporter, therapeutic target, or clinical biomarker. For structured database purposes, this locus should not be treated as an actionable or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 6 (KRT18P6).